Net Income Per Share of Common Stock

6 Months Ended

Jun. 30, 2025

Net Income Per Share of Common Stock [Abstract]

Basic net (loss) / income per share is based on the weighted average number of shares of common stock outstanding during the period, which does not include unvested restricted common stock subject to forfeiture of 1,757 shares for the period ended June 30, 2025, compared to 1,629 shares for the period ended June 30, 2024. Diluted net (loss) / income per share reflects: a) the potential dilution assuming shares of common stock were issued upon the exercise of outstanding in-the-money options and the assumed proceeds, which are deemed to be the proceeds from the exercise plus compensation cost not yet recognized attributable to future services using the treasury method, were used to purchase shares of the Company’s common stock at the average market price during the period, b) the vesting of granted non-vested restricted stock awards for which the assumed proceeds upon vesting are deemed to be the amount of compensation cost not yet recognized attributable to future services using the treasury stock method, to the extent dilutive, and c) issued performance-based awards to the extent that the underlying performance conditions (i) have been satisfied as of the end of the reporting period or (ii) would be considered satisfied if the end of the reporting period were the end of the related contingency period and the result would be dilutive.


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024

Net (loss) / income attributable to Steven Madden, Ltd.	$	(39,477)	$	35,376	$	946	$	79,310

Basic net (loss) / income per share	$	(0.56)	$	0.50	$	0.01	$	1.10

Diluted net (loss) / income per share	$	(0.56)	$	0.49	$	0.01	$	1.09

Weighted average common shares outstanding:
Basic	70,870		71,458		70,822		71,875
Effect of dilutive securities:
Stock awards and options to purchase shares of common stock	—		546		148		555
Diluted	70,870		72,004		70,970		72,430

For the three and six months ended June 30, 2025, options to purchase approximately 1 and 2 shares of common stock, in each period, have been excluded from the calculation of diluted net (loss) / income per share as the result would have been anti-dilutive. For the three and six months ended June 30, 2024, options to purchase approximately 24 and 12 shares of common stock have been excluded from the calculation of diluted net income per share as the result would have been anti-dilutive.

For the three and six months ended June 30, 2025, 697 and 286 restricted shares were excluded from the calculation of diluted net loss per share, compared to approximately 1 and 5 shares that were excluded from the calculation of diluted net income per share for the three and six months ended June 30, 2024, as the result would have been anti-dilutive. The Company had certain contingently issuable performance awards outstanding that did not meet the performance conditions as of June 30, 2025 and 2024 and, therefore, were excluded from the calculation of diluted net (loss) / income per common share for the three and six months ended June 30, 2025 and 2024. The number of potentially dilutive shares that could be issued upon vesting for these performance-based awards were immaterial as of both June 30, 2025 and 2024. These amounts were also excluded from the computation of weighted average potentially dilutive securities.